{"entity":{"type":"insider","cik":"0001307729","url":"/insider/0001307729","json_url":"/insider/0001307729.json","name":"Baker Brothers Life Sciences Capital (GP), LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":647,"n_filings":186,"first":"2005-02-14","last":"2012-03-14","span_basis":"filed_date"},"name_variants":[{"name":"Baker Brothers Life Sciences Capital (GP), LLC","source":"filing","n_filings":174,"first_seen":"2006-05-25","last_seen":"2012-03-14"},{"name":"Baker Biotech Capital III (GP), LLC","source":"filing","n_filings":12,"first_seen":"2005-02-14","last_seen":"2006-03-01"}],"transactions":[{"id":2958561,"accession":"0001144204-12-014965","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001144204-12-014965","line_url":"/filing/0001144204-12-014965","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"TRANZYME INC","issuer_ticker":"TZYM","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"BAKER FELIX; Baker Brothers Life Sciences Capital (GP), LLC; BAKER JULIAN","owner_display_name":"BAKER FELIX","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":90838.0,"shares_display":"90,838","price_per_share":2.9953366146326426,"price_display":"3.00","price_state":"stated","total_value":272090.3874,"total_display":"272,090.39","total_whole":"272,090","shares_owned_after":3505471.0,"shares_owned_after_display":"3,505,471","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-03-14","filed_date":"2012-03-14","scope":"insider","n_lines":2},{"id":2958548,"accession":"0001144204-12-014965","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001144204-12-014965","line_url":"/filing/0001144204-12-014965#line-5","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"TRANZYME INC","issuer_ticker":"TZYM","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"BAKER FELIX; Baker Brothers Life Sciences Capital (GP), LLC; BAKER JULIAN","owner_display_name":"BAKER FELIX","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":159015.0,"shares_display":"159,015","price_per_share":2.9581,"price_display":"2.96","price_state":"stated","total_value":470382.2715,"total_display":"470,382.27","total_whole":"470,382","shares_owned_after":3449177.0,"shares_owned_after_display":"3,449,177","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-03-13","filed_date":"2012-03-14","scope":"insider"},{"id":2958542,"accession":"0001144204-12-014965","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-12-014965","line_url":"/filing/0001144204-12-014965","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"TRANZYME INC","issuer_ticker":"TZYM","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"BAKER FELIX; Baker Brothers Life Sciences Capital (GP), LLC; BAKER JULIAN","owner_display_name":"BAKER FELIX","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":961299.0,"shares_display":"961,299","price_per_share":2.4355258490854563,"price_display":"2.44","price_state":"stated","total_value":2341268.5632,"total_display":"2,341,268.56","total_whole":"2,341,269","shares_owned_after":3290162.0,"shares_owned_after_display":"3,290,162","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-03-12","filed_date":"2012-03-14","scope":"insider","n_lines":4},{"id":3419695,"accession":"0001144204-12-014099","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-12-014099","line_url":"/filing/0001144204-12-014099#line-2","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"BAKER FELIX; Baker Brothers Life Sciences Capital (GP), LLC; BAKER JULIAN","owner_display_name":"BAKER FELIX","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19513.0,"shares_display":"19,513","price_per_share":30.3638,"price_display":"30.36","price_state":"stated","total_value":592488.8294,"total_display":"592,488.83","total_whole":"592,489","shares_owned_after":8255421.0,"shares_owned_after_display":"8,255,421","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-03-08","filed_date":"2012-03-09","scope":"insider"},{"id":3419693,"accession":"0001144204-12-014099","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-12-014099","line_url":"/filing/0001144204-12-014099#line-1","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"BAKER FELIX; Baker Brothers Life Sciences Capital (GP), LLC; BAKER JULIAN","owner_display_name":"BAKER FELIX","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22071.0,"shares_display":"22,071","price_per_share":29.8792,"price_display":"29.88","price_state":"stated","total_value":659463.8232,"total_display":"659,463.82","total_whole":"659,464","shares_owned_after":8235908.0,"shares_owned_after_display":"8,235,908","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-03-07","filed_date":"2012-03-09","scope":"insider"},{"id":2543324,"accession":"0001144204-12-013006","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-12-013006","line_url":"/filing/0001144204-12-013006","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"Baker Brothers Life Sciences Capital (GP), LLC; BAKER JULIAN; BAKER FELIX","owner_display_name":"Baker Brothers Life Sciences Capital (GP), LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":155014.0,"shares_display":"155,014","price_per_share":30.006834411730555,"price_display":"30.01","price_state":"stated","total_value":4651479.4295,"total_display":"4,651,479.43","total_whole":"4,651,479","shares_owned_after":8144054.0,"shares_owned_after_display":"8,144,054","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-03-05","filed_date":"2012-03-05","scope":"insider","n_lines":2},{"id":2543312,"accession":"0001144204-12-013006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-12-013006","line_url":"/filing/0001144204-12-013006#line-2","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"Baker Brothers Life Sciences Capital (GP), LLC; BAKER JULIAN; BAKER FELIX","owner_display_name":"Baker Brothers Life Sciences Capital (GP), LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":91459.0,"shares_display":"91,459","price_per_share":29.5205,"price_display":"29.52","price_state":"stated","total_value":2699915.4095,"total_display":"2,699,915.41","total_whole":"2,699,915","shares_owned_after":8058823.0,"shares_owned_after_display":"8,058,823","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-03-02","filed_date":"2012-03-05","scope":"insider"},{"id":2543305,"accession":"0001144204-12-013006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-12-013006","line_url":"/filing/0001144204-12-013006#line-1","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"Baker Brothers Life Sciences Capital (GP), LLC; BAKER JULIAN; BAKER FELIX","owner_display_name":"Baker Brothers Life Sciences Capital (GP), LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15288.0,"shares_display":"15,288","price_per_share":29.4704,"price_display":"29.47","price_state":"stated","total_value":450543.4752,"total_display":"450,543.48","total_whole":"450,543","shares_owned_after":7967364.0,"shares_owned_after_display":"7,967,364","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-03-01","filed_date":"2012-03-05","scope":"insider"},{"id":2343382,"accession":"0001144204-12-012152","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-12-012152","line_url":"/filing/0001144204-12-012152#line-3","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"Baker Brothers Life Sciences Capital (GP), LLC; BAKER JULIAN; BAKER FELIX","owner_display_name":"Baker Brothers Life Sciences Capital (GP), LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":156902.0,"shares_display":"156,902","price_per_share":29.0581,"price_display":"29.06","price_state":"stated","total_value":4559274.0062,"total_display":"4,559,274.01","total_whole":"4,559,274","shares_owned_after":7952076.0,"shares_owned_after_display":"7,952,076","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-02-29","filed_date":"2012-02-29","scope":"insider"},{"id":2343377,"accession":"0001144204-12-012152","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-12-012152","line_url":"/filing/0001144204-12-012152#line-2","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"Baker Brothers Life Sciences Capital (GP), LLC; BAKER JULIAN; BAKER FELIX","owner_display_name":"Baker Brothers Life Sciences Capital (GP), LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":51248.0,"shares_display":"51,248","price_per_share":29.1085,"price_display":"29.11","price_state":"stated","total_value":1491752.408,"total_display":"1,491,752.41","total_whole":"1,491,752","shares_owned_after":7795174.0,"shares_owned_after_display":"7,795,174","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-02-28","filed_date":"2012-02-29","scope":"insider"},{"id":2343373,"accession":"0001144204-12-012152","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-12-012152","line_url":"/filing/0001144204-12-012152#line-1","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"Baker Brothers Life Sciences Capital (GP), LLC; BAKER JULIAN; BAKER FELIX","owner_display_name":"Baker Brothers Life Sciences Capital (GP), LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":36881.0,"shares_display":"36,881","price_per_share":29.0306,"price_display":"29.03","price_state":"stated","total_value":1070677.5586,"total_display":"1,070,677.56","total_whole":"1,070,678","shares_owned_after":7743926.0,"shares_owned_after_display":"7,743,926","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-02-27","filed_date":"2012-02-29","scope":"insider"},{"id":2914828,"accession":"0001144204-12-010672","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-12-010672","line_url":"/filing/0001144204-12-010672#line-3","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"BAKER FELIX; BAKER JULIAN; Baker Brothers Life Sciences Capital (GP), LLC","owner_display_name":"BAKER FELIX","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":62098.0,"shares_display":"62,098","price_per_share":28.1238,"price_display":"28.12","price_state":"stated","total_value":1746431.7324,"total_display":"1,746,431.73","total_whole":"1,746,432","shares_owned_after":7707045.0,"shares_owned_after_display":"7,707,045","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-02-23","filed_date":"2012-02-23","scope":"insider"},{"id":2914823,"accession":"0001144204-12-010672","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-12-010672","line_url":"/filing/0001144204-12-010672#line-2","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"BAKER FELIX; BAKER JULIAN; Baker Brothers Life Sciences Capital (GP), LLC","owner_display_name":"BAKER FELIX","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5511.0,"shares_display":"5,511","price_per_share":27.9811,"price_display":"27.98","price_state":"stated","total_value":154203.8421,"total_display":"154,203.84","total_whole":"154,204","shares_owned_after":7644947.0,"shares_owned_after_display":"7,644,947","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-02-22","filed_date":"2012-02-23","scope":"insider"},{"id":2914817,"accession":"0001144204-12-010672","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-12-010672","line_url":"/filing/0001144204-12-010672#line-1","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"BAKER FELIX; BAKER JULIAN; Baker Brothers Life Sciences Capital (GP), LLC","owner_display_name":"BAKER FELIX","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":46909.0,"shares_display":"46,909","price_per_share":27.9769,"price_display":"27.98","price_state":"stated","total_value":1312368.4021,"total_display":"1,312,368.40","total_whole":"1,312,368","shares_owned_after":7639436.0,"shares_owned_after_display":"7,639,436","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-02-21","filed_date":"2012-02-23","scope":"insider"},{"id":2846181,"accession":"0001144204-12-009721","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001144204-12-009721","line_url":"/filing/0001144204-12-009721","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"BAKER FELIX; BAKER JULIAN; Baker Brothers Life Sciences Capital (GP), LLC","owner_display_name":"BAKER FELIX","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":184980.0,"shares_display":"184,980","price_per_share":29.730227060763326,"price_display":"29.73","price_state":"stated","total_value":5499497.4017,"total_display":"5,499,497.40","total_whole":"5,499,497","shares_owned_after":7500984.0,"shares_owned_after_display":"7,500,984","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-02-16","filed_date":"2012-02-16","scope":"insider","n_lines":3},{"id":2846167,"accession":"0001144204-12-009721","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-12-009721","line_url":"/filing/0001144204-12-009721#line-2","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"BAKER FELIX; BAKER JULIAN; Baker Brothers Life Sciences Capital (GP), LLC","owner_display_name":"BAKER FELIX","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":32125.0,"shares_display":"32,125","price_per_share":28.8772,"price_display":"28.88","price_state":"stated","total_value":927680.05,"total_display":"927,680.05","total_whole":"927,680","shares_owned_after":7407547.0,"shares_owned_after_display":"7,407,547","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-02-15","filed_date":"2012-02-16","scope":"insider"},{"id":2846163,"accession":"0001144204-12-009721","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-12-009721","line_url":"/filing/0001144204-12-009721#line-1","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"BAKER FELIX; BAKER JULIAN; Baker Brothers Life Sciences Capital (GP), LLC","owner_display_name":"BAKER FELIX","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":55804.0,"shares_display":"55,804","price_per_share":28.437,"price_display":"28.44","price_state":"stated","total_value":1586898.348,"total_display":"1,586,898.35","total_whole":"1,586,898","shares_owned_after":7375422.0,"shares_owned_after_display":"7,375,422","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-02-14","filed_date":"2012-02-16","scope":"insider"},{"id":3327112,"accession":"0001144204-12-007402","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001144204-12-007402","line_url":"/filing/0001144204-12-007402","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"Baker Brothers Life Sciences Capital (GP), LLC; BAKER JULIAN; BAKER FELIX","owner_display_name":"Baker Brothers Life Sciences Capital (GP), LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":159832.0,"shares_display":"159,832","price_per_share":26.5899893031433,"price_display":"26.59","price_state":"stated","total_value":4249931.1703,"total_display":"4,249,931.17","total_whole":"4,249,931","shares_owned_after":7272521.0,"shares_owned_after_display":"7,272,521","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-02-10","filed_date":"2012-02-10","scope":"insider","n_lines":3},{"id":3327101,"accession":"0001144204-12-007402","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001144204-12-007402","line_url":"/filing/0001144204-12-007402","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"Baker Brothers Life Sciences Capital (GP), LLC; BAKER JULIAN; BAKER FELIX","owner_display_name":"Baker Brothers Life Sciences Capital (GP), LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":55994.0,"shares_display":"55,994","price_per_share":26.317611326213523,"price_display":"26.32","price_state":"stated","total_value":1473628.3286,"total_display":"1,473,628.33","total_whole":"1,473,628","shares_owned_after":7155903.0,"shares_owned_after_display":"7,155,903","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-02-09","filed_date":"2012-02-10","scope":"insider","n_lines":3},{"id":3327086,"accession":"0001144204-12-007402","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-12-007402","line_url":"/filing/0001144204-12-007402","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"Baker Brothers Life Sciences Capital (GP), LLC; BAKER JULIAN; BAKER FELIX","owner_display_name":"Baker Brothers Life Sciences Capital (GP), LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":202089.0,"shares_display":"202,089","price_per_share":26.19916748066446,"price_display":"26.20","price_state":"stated","total_value":5294563.557,"total_display":"5,294,563.56","total_whole":"5,294,564","shares_owned_after":7043477.0,"shares_owned_after_display":"7,043,477","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-02-08","filed_date":"2012-02-10","scope":"insider","n_lines":3},{"id":3384887,"accession":"0001144204-12-005867","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-12-005867","line_url":"/filing/0001144204-12-005867#line-1","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"Ardea Biosciences, Inc./DE","issuer_ticker":"RDEA","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"BAKER FELIX; BAKER JULIAN; Baker Brothers Life Sciences Capital (GP), LLC","owner_display_name":"BAKER FELIX","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":876828.0,"shares_display":"876,828","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":14906076.0,"total_display":"14,906,076.00","total_whole":"14,906,076","shares_owned_after":4922226.0,"shares_owned_after_display":"4,922,226","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-02-01","filed_date":"2012-02-03","scope":"insider"},{"id":2265038,"accession":"0001144204-12-004225","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001144204-12-004225","line_url":"/filing/0001144204-12-004225","is_derivative":false,"issuer_cik":"0000949699","issuer_name":"PHARMACYCLICS INC","issuer_ticker":"PCYC","issuer_name_source":null,"issuer_url":"/issuer/0000949699","owner_cik":null,"owner_name":"BAKER FELIX; BAKER JULIAN; Baker Brothers Life Sciences Capital (GP), LLC","owner_display_name":"BAKER FELIX","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":243790.0,"shares_display":"243,790","price_per_share":17.932852151031625,"price_display":"17.93","price_state":"stated","total_value":4371850.0259,"total_display":"4,371,850.03","total_whole":"4,371,850","shares_owned_after":8499296.0,"shares_owned_after_display":"8,499,296","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-01-26","filed_date":"2012-01-26","scope":"insider","n_lines":2},{"id":2265030,"accession":"0001144204-12-004225","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-12-004225","line_url":"/filing/0001144204-12-004225","is_derivative":false,"issuer_cik":"0000949699","issuer_name":"PHARMACYCLICS INC","issuer_ticker":"PCYC","issuer_name_source":null,"issuer_url":"/issuer/0000949699","owner_cik":null,"owner_name":"BAKER FELIX; BAKER JULIAN; Baker Brothers Life Sciences Capital (GP), LLC","owner_display_name":"BAKER FELIX","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":125551.0,"shares_display":"125,551","price_per_share":18.53123361422848,"price_display":"18.53","price_state":"stated","total_value":2326614.9115,"total_display":"2,326,614.91","total_whole":"2,326,615","shares_owned_after":8313084.0,"shares_owned_after_display":"8,313,084","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-01-25","filed_date":"2012-01-26","scope":"insider","n_lines":2},{"id":2265022,"accession":"0001144204-12-004225","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-12-004225","line_url":"/filing/0001144204-12-004225","is_derivative":false,"issuer_cik":"0000949699","issuer_name":"PHARMACYCLICS INC","issuer_ticker":"PCYC","issuer_name_source":null,"issuer_url":"/issuer/0000949699","owner_cik":null,"owner_name":"BAKER FELIX; BAKER JULIAN; Baker Brothers Life Sciences Capital (GP), LLC","owner_display_name":"BAKER FELIX","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":131311.0,"shares_display":"131,311","price_per_share":17.95425564347237,"price_display":"17.95","price_state":"stated","total_value":2357591.2628,"total_display":"2,357,591.26","total_whole":"2,357,591","shares_owned_after":8205104.0,"shares_owned_after_display":"8,205,104","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-01-24","filed_date":"2012-01-26","scope":"insider","n_lines":2},{"id":3355959,"accession":"0001144204-12-003574","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001144204-12-003574","line_url":"/filing/0001144204-12-003574","is_derivative":false,"issuer_cik":"0000949699","issuer_name":"PHARMACYCLICS INC","issuer_ticker":"PCYC","issuer_name_source":null,"issuer_url":"/issuer/0000949699","owner_cik":null,"owner_name":"Baker Brothers Life Sciences Capital (GP), LLC; BAKER FELIX; BAKER JULIAN","owner_display_name":"Baker Brothers Life Sciences Capital (GP), LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":162215.0,"shares_display":"162,215","price_per_share":16.872722358598157,"price_display":"16.87","price_state":"stated","total_value":2737008.6574,"total_display":"2,737,008.66","total_whole":"2,737,009","shares_owned_after":8028219.0,"shares_owned_after_display":"8,028,219","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-01-23","filed_date":"2012-01-23","scope":"insider","n_lines":3},{"id":3355946,"accession":"0001144204-12-003574","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001144204-12-003574","line_url":"/filing/0001144204-12-003574","is_derivative":false,"issuer_cik":"0000949699","issuer_name":"PHARMACYCLICS INC","issuer_ticker":"PCYC","issuer_name_source":null,"issuer_url":"/issuer/0000949699","owner_cik":null,"owner_name":"Baker Brothers Life Sciences Capital (GP), LLC; BAKER FELIX; BAKER JULIAN","owner_display_name":"Baker Brothers Life Sciences Capital (GP), LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":248166.0,"shares_display":"248,166","price_per_share":16.416352451987784,"price_display":"16.42","price_state":"stated","total_value":4073980.5226,"total_display":"4,073,980.52","total_whole":"4,073,981","shares_owned_after":7817433.0,"shares_owned_after_display":"7,817,433","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-01-20","filed_date":"2012-01-23","scope":"insider","n_lines":2},{"id":3355941,"accession":"0001144204-12-003574","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-12-003574","line_url":"/filing/0001144204-12-003574","is_derivative":false,"issuer_cik":"0000949699","issuer_name":"PHARMACYCLICS INC","issuer_ticker":"PCYC","issuer_name_source":null,"issuer_url":"/issuer/0000949699","owner_cik":null,"owner_name":"Baker Brothers Life Sciences Capital (GP), LLC; BAKER FELIX; BAKER JULIAN","owner_display_name":"Baker Brothers Life Sciences Capital (GP), LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":34857.0,"shares_display":"34,857","price_per_share":16.05011453366612,"price_display":"16.05","price_state":"stated","total_value":559458.8423,"total_display":"559,458.84","total_whole":"559,459","shares_owned_after":7625736.0,"shares_owned_after_display":"7,625,736","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-01-19","filed_date":"2012-01-23","scope":"insider","n_lines":3},{"id":3179232,"accession":"0001144204-12-002686","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001144204-12-002686","line_url":"/filing/0001144204-12-002686#line-5","is_derivative":false,"issuer_cik":"0000879169","issuer_name":"INCYTE CORP","issuer_ticker":"INCY","issuer_name_source":null,"issuer_url":"/issuer/0000879169","owner_cik":null,"owner_name":"Baker Brothers Life Sciences Capital (GP), LLC; BAKER JULIAN; BAKER FELIX","owner_display_name":"Baker Brothers Life Sciences Capital (GP), LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":102856.0,"shares_display":"102,856","price_per_share":16.4573,"price_display":"16.46","price_state":"stated","total_value":1692732.0488,"total_display":"1,692,732.05","total_whole":"1,692,732","shares_owned_after":12316128.0,"shares_owned_after_display":"12,316,128","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-01-13","filed_date":"2012-01-17","scope":"insider"},{"id":3179226,"accession":"0001144204-12-002686","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-12-002686","line_url":"/filing/0001144204-12-002686#line-4","is_derivative":false,"issuer_cik":"0000879169","issuer_name":"INCYTE CORP","issuer_ticker":"INCY","issuer_name_source":null,"issuer_url":"/issuer/0000879169","owner_cik":null,"owner_name":"Baker Brothers Life Sciences Capital (GP), LLC; BAKER JULIAN; BAKER FELIX","owner_display_name":"Baker Brothers Life Sciences Capital (GP), LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":72978.0,"shares_display":"72,978","price_per_share":16.5779,"price_display":"16.58","price_state":"stated","total_value":1209821.9862,"total_display":"1,209,821.99","total_whole":"1,209,822","shares_owned_after":12389106.0,"shares_owned_after_display":"12,389,106","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-01-13","filed_date":"2012-01-17","scope":"insider"}],"collapsed":true,"next_cursor":"2012-01-13|3179226","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001274644","name":"TRANZYME INC","url":"/issuer/0001274644","role":"Ten percent owner","n_filings":1,"first_seen":"2012-03-14","last_seen":"2012-03-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001131324","name":"GENOMIC HEALTH INC","url":"/issuer/0001131324","role":"Director, Ten percent owner","n_filings":42,"first_seen":"2005-10-06","last_seen":"2012-03-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001103390","name":"Ardea Biosciences, Inc./DE","url":"/issuer/0001103390","role":"Director, Ten percent owner","n_filings":13,"first_seen":"2005-04-14","last_seen":"2012-02-03"},{"type":"issuer","type_label":"ISSUER","cik":"0000949699","name":"PHARMACYCLICS INC","url":"/issuer/0000949699","role":"Ten percent owner","n_filings":7,"first_seen":"2011-08-24","last_seen":"2012-01-26"},{"type":"issuer","type_label":"ISSUER","cik":"0000879169","name":"INCYTE CORP","url":"/issuer/0000879169","role":"Director, Ten percent owner","n_filings":26,"first_seen":"2007-08-03","last_seen":"2012-01-17"},{"type":"issuer","type_label":"ISSUER","cik":"0000946840","name":"VIROPHARMA INC","url":"/issuer/0000946840","role":"Ten percent owner","n_filings":19,"first_seen":"2005-02-14","last_seen":"2011-12-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001060736","name":"SEATTLE GENETICS INC /WA","url":"/issuer/0001060736","role":"Director, Ten percent owner","n_filings":31,"first_seen":"2005-03-24","last_seen":"2011-09-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001182129","name":"AUXILIUM PHARMACEUTICALS INC","url":"/issuer/0001182129","role":"Ten percent owner","n_filings":5,"first_seen":"2010-03-11","last_seen":"2011-08-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001076167","name":"ADOLOR CORP","url":"/issuer/0001076167","role":"Ten percent owner","n_filings":5,"first_seen":"2010-04-28","last_seen":"2010-10-29"},{"type":"issuer","type_label":"ISSUER","cik":"0000911326","name":"TRIMERIS INC","url":"/issuer/0000911326","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2010-09-30","last_seen":"2010-09-30"},{"type":"issuer","type_label":"ISSUER","cik":"0000882796","name":"BIOCRYST PHARMACEUTICALS INC","url":"/issuer/0000882796","role":"Ten percent owner","n_filings":2,"first_seen":"2008-11-24","last_seen":"2009-06-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001097264","name":"ALLOS THERAPEUTICS INC","url":"/issuer/0001097264","role":"Ten percent owner","n_filings":12,"first_seen":"2006-11-20","last_seen":"2009-02-06"},{"type":"issuer","type_label":"ISSUER","cik":"0000891504","name":"TAPESTRY PHARMACEUTICALS, INC","url":"/issuer/0000891504","role":"Ten percent owner","n_filings":2,"first_seen":"2008-04-08","last_seen":"2008-10-17"},{"type":"issuer","type_label":"ISSUER","cik":"0000861838","name":"IDERA PHARMACEUTICALS, INC.","url":"/issuer/0000861838","role":"Ten percent owner","n_filings":20,"first_seen":"2007-06-22","last_seen":"2008-09-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001307729","retrieved_at":"2026-08-25T01:08:37+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}